OFI Invest Asset Management Decreases Stock Holdings in CME Group Inc. $CME

Key Points

• OFI Invest Asset Management reduced its stake in CME Group Inc. by 84.5%, now holding only 389 shares after selling 2,117 shares in the second quarter.
• Several hedge funds, including Heartland Bank & Trust and Catalyst Capital Advisors, increased their positions in CME Group during the first quarter, indicating varied investor sentiment.
• CME Group reported a 10.4% increase in quarterly revenue year-over-year, alongside earnings per share of $2.96, surpassing analysts' expectations.

OFI Invest Asset Management reduced its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 84.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 389 shares of the financial services provider's stock after selling 2,117 shares during the quarter. OFI Invest Asset Management's holdings in CME Group were worth $107,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Heartland Bank & Trust Co purchased a new stake in shares of CME Group during the 1st quarter worth $377,000. Catalyst Capital Advisors LLC lifted its stake in shares of CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after purchasing an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. purchased a new stake in shares of CME Group during the 1st quarter worth $367,000. Fulcrum Equity Management purchased a new stake in CME Group in the first quarter valued at about $258,000. Finally, AIA Group Ltd raised its stake in CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after buying an additional 2,510 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CME has been the subject of a number of research analyst reports. Citigroup upgraded CME Group from a "neutral" rating to a "buy" rating and increased their price target for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Weiss Ratings reiterated a "buy (b)" rating on shares of CME Group in a research note on Wednesday, October 8th. Jefferies Financial Group decreased their price target on CME Group from $313.00 to $304.00 and set a "buy" rating for the company in a research note on Friday. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $276.00 to $266.00 and set a "hold" rating for the company in a research note on Thursday. Finally, UBS Group decreased their price target on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research note on Monday, September 8th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $281.00.

Insider Transactions at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the firm's stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares of the company's stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by company insiders.

CME Group Trading Up 1.0%

Shares of NASDAQ:CME opened at $271.45 on Monday. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79. The stock has a market cap of $97.83 billion, a price-to-earnings ratio of 26.28, a PEG ratio of 5.72 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business has a 50-day moving average price of $268.89 and a 200-day moving average price of $271.29.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period last year, the business posted $2.56 earnings per share. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. Equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.